FindTrial
Sign In

Patient-reported outcomes (PROs)

OTHER2 trials

Sponsors

GenSight Biologics, University Health Network, Toronto

Conditions

CancerCancer, Therapy-RelatedGene FusionGenetic AlterationLeber Hereditary Optic NeuropathyMalignancies MultipleMalignant Solid TumorMolecular Sequence Variation

Unknown Phase

REALITY LHON Registry
CompletedNCT03295071
GenSight BiologicsLeber Hereditary Optic Neuropathy
Start: 2018-01-03End: 2020-07-01Updated: 2026-03-02
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
RecruitingNCT04151342
University Health Network, TorontoCancer, Cancer, Therapy-Related, Gene Fusion +7
Start: 2020-01-17End: 2029-12-31Target: 5500Updated: 2025-12-03

Related Papers

Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
2024-11-212 citations
Abstract 926: Adaptive universal platform for real-world observational studies (AUPROS): An emerging model for clinical, epidemiologic, and precision oncology research
Cancer Research2024-03-22
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation.
2022-11-3016 citations
Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison
Frontiers in Neurology2021-05-2456 citations